Overview of This Study:

The study involved four major activities in estimating the current size of the Sterile Filtration Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Projected Revenue Surge:

The global sterile filtration  market size is projected to reach USD 7.6 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 8.2%.

Driver: Advantages of sterile filters over non-sterile filters

The various advantages of sterile filters over non-sterile filters make them the preferred choice for upstream and downstream processing in the pharmaceutical biopharmaceutical and the food beverage industries. Sterile filters are available in various formats, namely, syringes, cartridges, capsules, and disposable sterile filter systems, for the optimal filtration of liquids and gases. Non-sterile filters are used for general filtration and sample purification.

Unlike non-sterile filters, sterile filters are more reliable for the removal of all microorganisms and particles from liquids or gases. In addition, sterile filters minimize the risk of contamination with complete ready-to-use units. These units are free of leachables extractables, have low adsorption characteristics, offer a fast flow rate, have a low dead volume (due to optimized membrane support), and result in no loss of protein (with a low protein affinity membrane).

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256410424

OPPORTUNITY: Emerging regions

Countries such as China, India, Brazil, and South Africa have experienced exponential economic growth in recent decades, resulting in a large and developing industrial base. This is also attributed to trade liberalization and market-oriented structural reforms, which have spurred economic growth in these countries.

As a result, emerging markets are becoming preferred as manufacturing and research locations for global players in the pharmaceutical industry and are being regarded as pharmerging markets. In 2018, for instance, Pall Corporation (Danaher), a leading player in the filtration market, opened a USD 2-million Nanyang Polytechnic (NYP) Center of Excellence in Singapore to showcase its single-use biopharmaceutical purification technologies.

Growing health concerns and strengthening of regulations, along with ongoing technological developments in the filtration equipment market, are transforming the pharmaceutical and food beverage industry in emerging markets—right from conventional methods of filtration to modern, sophisticated filtration methods. This is expected to drive the overall demand for sterile filtration equipment in emerging markets, thus providing growth opportunities for market players.

Geographical Growth Dynamics:

North America accounted for the largest share of the sterile filtration market in 2019

Based on the region, the sterile filtration market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East Africa. North America accounted for the largest share of the sterile filtration market in 2019. The large share of the North American region can be attributed to a large number of pharmaceutical and biotechnology and food beverage companies in the region, the presence of a well-established healthcare market, and stringent regulations for the pharmaceutical industry.

Recent Developments:

# In 2019, Merck (Germany) launched the Stericup Quick Release 500 ml Vacuum Filtration System.

# In 2019, Merck (Germany)) expanded its distribution capacity in Gillingham, UK.

# In 2019, Sartorius (Germany) launched Sartolab MultiStation (filtration units).

# In 2018, Pall (US) established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China. This center is equipped with advanced bioprocessing equipment, including single-use cell culture solutions, cell clarification using acoustic wave technology, chromatography using automated packing techniques, viral clearance, and tangential flow filtration, to serve bioprocess engineering consultancies for China and broader Asia.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=256410424

Key Market Players

Key players in the sterile filtration market are Merck KGaA (Germany) is the largest player in the global sterile filtration market. The company has expanded its position as the most profitable technology and solutions supplier in the sterile filtration industry by offering leading-edge products for biotech pharmaceutical companies and for the advancement of cell and gene therapy. The company also adopts organic strategies such as product launches and expansions to maintain its position in this market.

Some of the major players in the sterile filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), Parker Hannifin Corporation (US, Sterlitech Corporation (US), Alfa Laval AB (Sweden), and Thermo Fisher Scientific (US).